Delivra Health Brands Inc.
DHB.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.33% | 30.57% | -15.27% | 6.14% | 30.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.33% | 30.57% | -15.27% | 6.14% | 30.93% |
| Cost of Revenue | -5.33% | 50.01% | -12.01% | 30.38% | 10.34% |
| Gross Profit | -5.32% | 13.91% | -18.24% | -9.89% | 60.76% |
| SG&A Expenses | 1.69% | 24.17% | 25.21% | 21.74% | 11.18% |
| Depreciation & Amortization | -6.04% | -2.80% | -4.02% | -4.47% | -1.51% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.39% | 30.34% | 3.20% | 22.59% | 9.37% |
| Operating Income | -47.97% | -29.40% | -247.89% | -261.58% | 71.40% |
| Income Before Tax | -40.54% | -21.61% | -308.01% | 25,726.67% | 58.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -40.54% | -21.61% | -308.01% | 25,726.67% | 58.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.54% | -21.61% | -308.01% | 25,726.67% | 58.69% |
| EBIT | -47.97% | -29.40% | -247.89% | -261.58% | 71.40% |
| EBITDA | -71.65% | -93.83% | -113.04% | -97.01% | 149.50% |
| EPS Basic | -40.30% | -3.33% | -274.63% | 18,550.00% | 66.50% |
| Normalized Basic EPS | -40.48% | -3.57% | -287.18% | 78.92% | 66.13% |
| EPS Diluted | -40.30% | -3.33% | -274.63% | 18,550.00% | 66.50% |
| Normalized Diluted EPS | -40.48% | -3.57% | -287.18% | 78.92% | 66.13% |
| Average Basic Shares Outstanding | 0.00% | 17.90% | 19.00% | 23.71% | 23.75% |
| Average Diluted Shares Outstanding | 0.00% | 17.90% | 19.00% | 23.71% | 23.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |